Prognostic Factors in Childhood Acute Lymphoblastic Leukemia: Correlation with Treatment Response
In 1949 Dr. Zuelzer, in his note on progress in pediatric hematology, made a then passing observation that in childhood ALL, the level of WBC at diagnosis has a bearing on survival (1). He noted, in a group of children with leukemia treated before the days of chemotherapy, that those presenting with WBC 10,000 at diagnosis, survived longer than those presenting with higher WBC counts. Some nineteen years later in 1968, Hardisty and Till (2) observed that children with ALL presenting with mediastinal mass (ALL + MM) have a poor outcome and show distinctly different clinical characteristics and thus, may have a biologically different form of ALL compared to others. In a later study (3) we confirmed this and showed that children with ALL + MM tend to have higher WBC, higher hemoglobin and platelet counts at presentation; that this presentation is seen more often in boys of older age and that they relapse early and thei survival is shorter. From these modest beginnings we have come a long way in recognizing that childhood ALL is a heterogeneous disease both in terms of clinical presentation and biologic characteristics. It is now well accepted that treatment has to be “tailored”, keeping in mind the clinical prognostic factors and immunologic subtypes of ALL.
KeywordsAcute Lymphoblastic Leukemia Mediastinal Mass Central Nervous System Relapse Childhood Acute Lymphoblastic Leukemia Pediatric Oncology Group
Unable to display preview. Download preview PDF.
- 11.Ravindranath Y, Bhambhani K, Kelly JO et al: Central nervous system prophylaxis with intermittent intrathecal methotrexate and fractional radiation in childhood acute lymphoblastic leukemia. In: Central Nervous System Leukemia — Prevention and Treatment, Mastrangelo R, Poplack DG, Riccardi R (eds), Martinus Nijhoff, 1983.Google Scholar
- 17.Henze G, Langermann HJ, Ritter J et al: Treatment strategy for different risk groups in childhood acute lymphoblastic leukemia: A report from the BFM study group. In: Haematology and Blood Transfusion: Modern Trends in Human Leukemia IV, Vol 26, Neth R, Gallo RC, Graf H (eds), Berlin, Springer-Verlag, 1981, p. 87.Google Scholar
- 18.Henze G, Lampert F, Langermann HJ et al: Prognosis of acute lymphoblastic leukemia related to initial findings and treatment. In: 13th International Cancer Congress, Part D, Research and Treatment, Alan R. Liss, New York, 1983, pp. 445–449.Google Scholar
- 21.Ravindranath Y. Unpublished observations.Google Scholar
- 29.Coccia PF, Bleyer WA, Siegel SE et al for the Children’s Cancer Study Group: Reduced therapy for children with good prognosis acute lymphoblastic leukemia. Blood 58: 1372, 1981.Google Scholar